Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

LEXINGTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ...
August 01, 2019 07:30 ET | Source: Kaleido Biosciences

Kaleido Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update

LEXINGTON, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the...
July 31, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences to Present at the 39th Annual Canaccord Genuity Growth Conference

LEXINGTON, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the...
July 22, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences Appoints Jerald Korn as General Counsel and Corporate Secretary

LEXINGTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the...
July 15, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors

LEXINGTON, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the...
June 26, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement – Drug Development Summit

Members of leadership team to participate in sessions discussing the role of the microbiome in human disease Summit coincides with World Microbiome Day: June 27, 2019 LEXINGTON, Mass., June 26,...
June 03, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences to Present at the Goldman Sachs 40th Annual Global Healthcare Conference

LEXINGTON, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the...
May 02, 2019 07:30 ET | Source: Kaleido Biosciences

Kaleido Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update

LEXINGTON, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the...
April 12, 2019 07:30 ET | Source: Kaleido Biosciences

Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress™ 2019 (EASL)

LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the...
April 08, 2019 08:00 ET | Source: Kaleido Biosciences

Kaleido Biosciences Announces Key Appointments to Leadership Team

LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the...